Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron May 12, 2021 7:52pm

110 Views

Post# 33188704

todays trades

House Positions for C:VXL from 20210512 to 20210512

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
2 RBC	222,030	22,203	0.10	26,072	2,607	0.10	195,958	-19,596
79 CIBC	53,500	5,350	0.10	7,000	700	0.10	46,500	-4,650
9 BMO Nesbitt	25,000	2,500	0.10	5,000	500	0.10	20,000	-2,000
85 Scotia	7,908	822	0.104	0			7,908	-822
212 Virtu	1,500	150	0.10	408	42	0.103	1,092	-108
88 Credential	0			500	50	0.10	-500	50
68 Leede	167	16	0.096	675	70	0.104	-508	54
19 Desjardins	0			20,500	2,050	0.10	-20,500	2,050
7 TD Sec	57,375	5,882	0.103	121,735	12,305	0.101	-64,360	6,423
1 Anonymous	9,500	950	0.10	89,697	9,009	0.10	-80,197	8,059
80 National Bank	30,050	3,012	0.10	135,443	13,551	0.10	-105,393	10,539
TOTAL	407,030	40,885	0.10	407,030	40,884	0.10	0	-1